GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,905 Cr | ₹1,525 Cr | ₹1,326 Cr | ₹1,698 Cr | ₹1,355 Cr |
What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,905 Cr |
| Mar2024 | ₹1,525 Cr |
| Mar2023 | ₹1,326 Cr |
| Mar2022 | ₹1,698 Cr |
| Mar2021 | ₹1,355 Cr |
How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,905 Cr | 24.93 | |
| Mar2024 | ₹1,525 Cr | 14.97 | |
| Mar2023 | ₹1,326 Cr | -21.91 | |
| Mar2022 | ₹1,698 Cr | 25.38 | |
| Mar2021 | ₹1,355 Cr | - | |
Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,761.9 Cr | 2.2% | -3.2% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
-3.2% |
-6.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses